GNTX 34.97 Gentex Corp $GNTX Hit a 52 week high of 35.07

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 11:03 AM

GNTX 34.97 Gentex Corp $GNTX Hit a 52 week high of 35.07 Closing the day 09:45 at 34.97 +0.09 +0.26% With a day low of 34.82 and a total volume of 44,929.

GNTX Recent Posts: http://investorshangout.com/Gentex-Corp-GNTX-54256/

GNTX Gentex Corp Recent Headline News

Ford (F) Recalls Ranger Pickups with Faulty Takata Airbags - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 4:40PM CST
Ford Motor Co. (F) announced that it is recalling Ford Ranger pickup trucks from the U.S. due to the faulty air bags supplied by Takata Corp
F: 15.33 (-0.21), GNTX: 35.00 (+0.12), TM: 119.92 (+1.33), HMC: 31.51 (unch)

Can Cooper Tire (CTB) Grow on Product Launch & Cost Cuts? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 12:10PM CST
On Nov 13, 2014, we issued an updated research report on Cooper Tire & Rubber Co. (CTB).
STRT: 104.69 (+0.27), CTB: 32.54 (+0.42), GNTX: 35.00 (+0.12), TM: 119.92 (+1.33)

Stocks Turn Negative; LinkedIn Drops
at Investor's Business Daily - Mon Nov 17, 10:59AM CST
Stocks turned negative in late morning trading as new data from the Federal Reserve showed industrial production slipped in October. The Nasdaq fell 0.7%, the S&P 500 dropped 0.2% and the Dow Jones industrial average shed 0.1%. Volume was tracking...
LNKD: 224.47 (+1.19), FB: 74.51 (+0.27), GNTX: 35.00 (+0.12), PAYC: 25.05 (+0.20), TTM: 47.47 (-0.21)

General Motors (GM) Sells its 3 Millionth Vehicle in China - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:30PM CST
General Motors Company (GM) and its joint ventures completed the sale of this year's 3 millionth vehicle in China in Oct 2014
STRT: 104.69 (+0.27), GM: 31.98 (-0.33), GNTX: 35.00 (+0.12), TM: 119.92 (+1.33)

Ford (F) Europe Sales Rise 8.1% to 98,100 Units in October - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 12:40PM CST
Ford Motor Co. (F) reported an 8.1% year-over-year increase in sales to 98,100 vehicles in its 20 traditional European markets in Oct 2014
F: 15.33 (-0.21), STRT: 104.69 (+0.27), GNTX: 35.00 (+0.12), TM: 119.92 (+1.33)

Can Honda's (HMC) Product Launches Offset Rising Costs? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 11:10AM CST
On Nov 12, 2014, we issued an updated research report on Honda Motor Co., Ltd. (HMC).
STRT: 104.69 (+0.27), PLOW: 23.02 (+0.12), GNTX: 35.00 (+0.12), HMC: 31.51 (unch)

AutoZone (AZO) to Grow on Store Expansion & Share Buyback - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 10:40AM CST
On Nov 12, 2014, we issued an updated research report on AutoZone, Inc. (AZO).
STRT: 104.69 (+0.27), AZO: 567.67 (-0.39), PLOW: 23.02 (+0.12), GNTX: 35.00 (+0.12)

Meritor (MTOR) Q4 Earnings Beat Estimates on Higher Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 9:40AM CST
Meritor, Inc. (MTOR) reported adjusted income of 35 cents per share in the fourth quarter of fiscal 2014 that surpassed the Zacks Consensus Estimate of 16 cents
STRT: 104.69 (+0.27), GNTX: 35.00 (+0.12), TM: 119.92 (+1.33), MTOR: 14.15 (+0.17)

Meritor (MTOR) Soars: Stock Moves 12.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:46AM CST
Meritor, Inc. (MTOR) was a big mover last session, as the company saw its shares rise nearly 13% on the day.
STRT: 104.69 (+0.27), PLOW: 23.02 (+0.12), GNTX: 35.00 (+0.12), MTOR: 14.15 (+0.17)

Toyota Announces 3 Recalls for 361,800 Vehicles Globally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 1:50PM CST
Toyota (TM) is announcing three separate recalls, covering a total of 361,800 vehicles worldwide.
STRT: 104.69 (+0.27), PLOW: 23.02 (+0.12), GNTX: 35.00 (+0.12), TM: 119.92 (+1.33)

17.5% Return Seen to Date on SmarTrend Gentex Call (GNTX)
Comtex SmarTrend(R) - Wed Nov 12, 11:10AM CST
SmarTrend identified an Uptrend for Gentex (NASDAQ:GNTX) on October 21st, 2014 at $28.60. In approximately 3 weeks, Gentex has returned 17.48% as of today's recent price of $33.60.
GNTX: 35.00 (+0.12)

GM Alleged of Ordering Parts Long Before Recall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 3:52PM CST
General Motors Company (GM) had ordered about half a million replacement ignition switches almost two months before announcing the recall of vehicles
STRT: 104.69 (+0.27), GM: 31.98 (-0.33), GNTX: 35.00 (+0.12), DLPH: 71.39 (+0.54)

Cooper Tire (CTB) Q3 Earnings Beat Estimates, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 10:10AM CST
Shares of Cooper Tire (CTB) fell on Nov 7 even as the company's third-quarter earnings increased to 77 cents from breakeven earnings in the prior-year quarter.
STRT: 104.69 (+0.27), CTB: 32.54 (+0.42), GNTX: 35.00 (+0.12), TM: 119.92 (+1.33)

Ford's (F) China Sales Decline in October 2014, Rise YTD - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 6:10PM CST
Ford Motor Co. (F) sold 93,179 vehicles in China in Oct 2014. This reflects a 0.8% year-over-year decline.
F: 15.34 (-0.20), STRT: 104.69 (+0.27), GNTX: 35.00 (+0.12), TM: 119.92 (+1.33)

Magna International (MGA) Beats Q3 Earnings, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 11:00AM CST
Share price of Magna International Inc. (MGA) increased 2% to $104.95 on Nov 6, after the company reported adjusted earnings per share of $2.22 for the third quarter of 2014.
STRT: 104.69 (+0.27), MGA: 104.84 (+0.94), GNTX: 35.00 (+0.12), TM: 119.92 (+1.33)

Advance Auto Parts Down on Weak Outlook; Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 9:20AM CST
Shares of Advance Auto Parts (AAP) fell on Nov 6 as its guidance failed to meet expectations. Earnings for the third quarter exceeded the Zacks Consensus Estimate.
STRT: 104.69 (+0.27), AAP: 145.94 (+0.11), GNTX: 35.00 (+0.12), TM: 119.92 (+1.33)

Tesla Model X Release Postponed to Q3 2015 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 2:37PM CST
Tesla (TSLA) has delayed the release of the highly anticipated Model X by a few months to the third quarter of 2015.
TSLA: 258.97 (+4.99), STRT: 104.69 (+0.27), GNTX: 35.00 (+0.12), TM: 119.92 (+1.33)

Superior Industries Down on Q3 Earnings, Revenue Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 1:40PM CST
Share price of Superior Industries International, Inc. (SUP) decreased 3.7% on Nov 4 to $18.47 after the company reported third-quarter 2014 adjusted earnings of 7 cents per share.
STRT: 104.69 (+0.27), GNTX: 35.00 (+0.12), TM: 119.92 (+1.33), SUP: 18.49 (+0.16)

General Motors (GM) China Sales Rise 3.2% Y/Y in October - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 3:07PM CST
General Motors Company (GM) and its joint ventures in China recorded a 3.2% year-over-year increase in sales in the nation in Oct 2014, taking the figure to 291,371 vehicles
STRT: 104.69 (+0.27), GM: 31.98 (-0.33), GNTX: 35.00 (+0.12), TM: 119.92 (+1.33)

Tesla (TSLA) Q3 Loss Wider than Estimates, Revenues Surge - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 11:00AM CST
Tesla (TSLA) reported adjusted loss of 25 cents per share in the third quarter of 2014, significantly wider than the Zacks Consensus Estimate of a loss of 15 cents.
TSLA: 258.97 (+4.99), STRT: 104.69 (+0.27), GNTX: 35.00 (+0.12)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Ping An's Bold Green Moves Ahead of APEC 2026

By Owen Jenkins Updated Oct 25, 2026 Category News Views 163

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

RYBREVANT's Promising Results in HNSCC Treatment

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Community in Shock After Fatal Bakersfield Shooting

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...